Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Stockjet who wrote (1578)	4/24/1998 4:45:00 PM
From: HoodBuilder	Respond to of 9523

Stockjet, I'm with you on the $120 call, the trick will be to close there. The IMS numbers will IMHO show large scrips written this past week, I'd guess 50,000+. The beauty of this stock is not just Viagra but the additional products in the pipeline. Unlike VVUS, PFE will be around for decades even after the hoopla wears off surrounding the "V" drug. Loaded up with more VPEAB's and May 115 Calls. Not even a 120 point dip in the Dow can stop this mother as evidenced by today's strength.

To: Stockjet who wrote (1578)	4/24/1998 4:47:00 PM
From: Anthony Wong	Respond to of 9523

Stockjet, I hadn't noticed that it closed above $118 until your post. The last time I checked, it was under $117. Heard on CNBC all day from analysts who said that some pharms and consumer stocks have too high valuations and are due for a correction if the market corrects 7% or more. It seems this time it's the small investors versus big institutions. All the friends I have spoken with wants to buy some PFE stock (be it 30, 50 or 100 shares) and put them away long term. If all Viagra users each buy 10 shares of PFE, there'll be a lot of shares hoarded away.